Australian (ASX) Stock Market Forum

WFL - Wellfully Limited

Joined
6 November 2005
Posts
915
Reactions
0
:)

Hi folks,

OBJ ... has been kind to us, with the good
news coming in, on schedule .....

..... thank you, Mr Gann.

It's not often, that we take any notice of
the fundamentals of any company.

However, this one is of particular interest.

To explain ..... whilst the recent increase in
Cortisone delivery is good news, it is the
Naltrexone patch that may well give OBJ
a boost in the short-term.

As volunteers on the fringes of the local
Naltrexone implant program, we can see
both the benefits and pitfalls of a
Naltrexone patch.

Competition for the Naltrexone patch is
very real, but the patch will have its place
in the rehabilitation of addicts.

In reality, a heroin-dependent addict does
not have the will-power or the mindset to
wear a patch of any type .....

..... that's where the Naltrexone implant
program kicks in, taking away the option
of refusing treatment for addicts coming
off heroin cold-turkey, by inserting the
Naltrexone under the skin, where it is
slowly used by the body to reduce the
addicts desire for opiates.

Where the OBJ patch may be of benefit is
where addicts have had an implant and have
had a change in mindset to long-term
recovery, as they progress with their
rehabilitation ..... though they still have the
option of removing the patch, with good
after-care and support, the necessity of a
subsequent implant may be reduced.

=====

If you check the Naltrexone articles in SMH
on 05122005, you will see that the Federal
Health Minister is very keen to promote
Naltrexone over methadone treatment,
because very few addicts ever leave the
methadone program and it costs the health
system more than $22 + million, every year.

Methadone is very damaging to dental
health as well, adding further to the annual
bill for just maintaining addicts, inside the
methadone program.

----

So, patches do have a place in the
recovery process for addicts, but promoting
them as primary treatment against the
established competition, like Naltrexone
implants would be a basic marketing error.

In short, Naltrexone patches are probably
best utilized on individuals, who are highly
committed to their own recovery, whether
they are being treated for alcohol addiction
or opiate-dependency.

Strangely, Naltrexone for alcoholism is
currently available through the public health
Medicare system, yet Naltrexone for drug
addicts must be paid for by the patient or
generous public donations ..... something
seems very wrong with that arrangement,
from here.

=====

These key dates for OBJ were previously
posted, on 07112005:

OBJ ..... technically, looking healthier
and time cycles look reasonably positive,
until mid-February 2006 ..... :)

14112005 ..... minor

30112005 ..... minor

13122005 ..... significant spotlight on OBJ

19122005 ..... 2 major time cycles here.

29122005 ..... significant news ???

12012006 ..... minor

17-18012006 ..... news about finances (???)

30-31012006 ..... minor

03-06022006 ..... minor and positive news

10022006 ..... minor and positive

20-22022006 ..... major time cycle and negative news (???)

10-13032006 ..... significant and negative

29032006 ..... minor and positive (finances???)

30-31032006 ..... significant and negative.

happy days

yogi

:)
 
Re: OBJ alert ..... astrostuff .....

Sounds really useful and makes a lot more sense than using methadone.

The methadone programme is simply exchanging one opiate for another.


Julia
 
Hi all,

Decided to take a punt on OBJ during the last week since selling out of CTP.

As you can see, they are a biotech. They are hoping to get their product linked to a commercial agreement early in the new year.

Be aware, such agreements are not guaranteed and this might not occur. That said, the ASX releases suggest the product is going well and a commercial agreement is a possibility.

At current SP, the leverege is huge.
One I am happy to hold and wait...


Holding OBJ at .007 ave:)
 
Hi all,

Decided to take a punt on OBJ during the last week since selling out of CTP.

As you can see, they are a biotech. They are hoping to get their product linked to a commercial agreement early in the new year.

Be aware, such agreements are not guaranteed and this might not occur. That said, the ASX releases suggest the product is going well and a commercial agreement is a possibility.

At current SP, the leverege is huge.
One I am happy to hold and wait...


Holding OBJ at .007 ave:)


OBJ seems to have taken off in a fenzy this morning.
It has risen nearly 50% on trade today - over 50m shares traded.

While I am loving to see this stock take off,
I am unaware of any new announcement to be released immediately that would be driving this reaction​
. Truthfully, I never expected such a market response as I said I was happy to hold and wait. Still, I am happy to be shocked!:)
Not sure why the sudden SP acceleration other than many investors see the potential of a commercialisation contract on a company with a low SP that offers leverege (as I posted above).


Continuing to hold OBJ at .007c
 
Been holding at .005 since April, nice to see this one on the move:cool:

Hopefully the good news keeps coming.

cheers
 
What a day! From .014 to .026 in a single day. When I bought this a few days ago, I managed to average in at .007c - never imagined this response.

Enjoying the ride and happy to simply sit back and watch this one grow. :p:


Holding OBJ at .007c
 
Congratulations! You all guys are lucky to hold it . Best of luck, tomorrow it will rise more.
Unfortunately not holding.
 
Thanks, Albi.

Sold a quarter to get myself free-carried today.

Now happy to wait and see when we get an update on commercial contracts.


Holding OBJ @ .007c
 
OBJ (ASX: OBJ) wishes to advise shareholders that it has entered into a Materials Transfer Agreement (MTA) with 3M Corporation of St Paul, Minnesota USA, for the evaluation of the Company’s eM‐patch ® technologies as an approach to enhance transdermal drug delivery. 3M is an American multinational corporation with 79,000 employees operating in 60 countries generating global sales in excess of US$25
billion in 2008. The evaluation will be conducted by the 3M Drug Delivery Systems division which has been a leader in drug delivery for more than 50 years and has extensive expertise in toxicology, regulatory, manufacturing, uality assurance and operations.

The Materials Transfer Agreement sets the parameters for an initial in vitro testing program to evaluate the performance of the eM‐patch ® technology in conjunction with 3M drug delivery platforms and proprietary formulations. The evaluation program is expected to be completed by 1st February 2010.


Great announcement today. 3M is no small technology slouch...this is a good connection for OBJ to make. Q1 next year should be very interesting when results come through by February :)

Happily holding OBJ at .007c
 
Also a great reaction from the market, going from 5 trades before the announcement to over 300 in the last hour of trade not to mention nearly a price double
 
Happy with the day so far.
Not sure if it can keep the momentum until mid-January but happy to hold as I am free-carried so will wait for news in early February.

Holding OBJ at .007c :)
 
Nice entry, im in from .19 but no complaints here. With the amount of trades taking place today its obvious lots of day trading, yet no doubt there is a certain investor aspect. I am quiet happy holding for a while as I can still see good potential before the evaluation is finished. Tomorrow's opening will be significant and interesting. :)
 
Great day for OBJ given no announcement. Just confirms why I would not be out of this one. Never mind early February results of the trials, you never can be 100% sure what other discussions are going on behind closed doors.
For me, I am in and will wait through to February.


Free-carried at .007c :)
 
BSEBS and other OBJ holders

Tomorrow is your day with Speculator David H speculated on OBJ with buy some shares and intending to take the rights offer.

WIth his earlier prediction I will not be surprised to see OBJ catapuled tomorrow:banghead:
 
BSEBS and other OBJ holders

Tomorrow is your day with Speculator David H speculated on OBJ with buy some shares and intending to take the rights offer.

WIth his earlier prediction I will not be surprised to see OBJ catapuled tomorrow:banghead:

ha ha

you party pooper, you spoiled the party.........

yep they will rocket and then correct.....fun times ahead on this one...
 
BSEBS and other OBJ holders

Tomorrow is your day with Speculator David H speculated on OBJ with buy some shares and intending to take the rights offer.

WIth his earlier prediction I will not be surprised to see OBJ catapuled tomorrow:banghead:

No how the hell did you find this out at 2.10 am and your 3 hours behind us....thats 11.10 PM AEST on Wed and our Eureka report was sent to us at 6.55pm on Thu AEST....whats the go....where are you finding this out and why so much earlier then the subscribers....
 
No how the hell did you find this out at 2.10 am and your 3 hours behind us....thats 11.10 PM AEST on Wed and our Eureka report was sent to us at 6.55pm on Thu AEST....whats the go....where are you finding this out and why so much earlier then the subscribers....

Looks like being Wait a While State WA I got something first time before the Eastern Philosophers.

I have no clue but I get the same email being subscriber supposedly same time.

No secret and predictably OBJ shot up by 29% . I think it is David H knows some inside story. Unfortunately (for the readers) he always buys first and then the market gets manipulated. If you are in the printing department of ER then every one there can make money first hand before the subscribers on whose money they are surviving. It is like shareholders invest and directors reap the benefits.

I will not be surprised like an elephant has two kinds of teeth - one for show and one to eat. David must be making his own purchase and sell first and then publishes the data next day for manipulating the market. He dealt with TRF and it went up. Sorry friend there was no special connection then I would be making some real money than paying subscription for Eureka Report and still can not catch the prediction :banghead:

Thanks for giving me some false glory or 14 seconds fame. :D
 
Thanks for the reply....I thought for a moment you where a printer, IT or staffer or somehow got the information early from one, which I suspect is happening....

None the less Im making great money following him, just got to be careful with the innevitable over reaction......

Im not in OBJ, have not had time to research it yet, but will be lloking closely....I will probably misss the rights offer which is likely to be a driving force for most buyers....stay tuned..
 
Happy to hold and watch this one.

Haven't thought too much about the SPP offer as yet. With The Speculator on board and such a large potential SP trigger if the February results are positive, this could run in January. At present, it seems to like the 3c mark. :)


Holding OBJ at .007c
 
Interesting couple of days for OBJ as it waits fro results in February:

1. Looks like The Speculator is now on the OBJ story. This might help to explain some of the latest volumes.

2. OBJ Ltd (ASX: OBJ) noted the overnight publication by the Journal of
Pharmaceutical Science of a paper into the enhanced transdermal delivery of
Naltrexone by the Companys technology.
The paper is published by Wiley Interscience and the American Pharmacists and I believe that it is a peer reviewed journal. Still no guarantees for February but slowly starts to build some credibility in the lead-up to results. Not surprised the SP rose to 3.2c on this. :)

Holding OBJ at .007c
 
Top